M&As this week: Johnson & Johnson, Acelity, CDH Genetech

Johnson & Johnson (J&J) has accepted a $2.1bn binding offer from Platinum Equity to acquire its blood glucose monitoring systems manufacturing subsidiary Lifescan Inc.